• Weekly Roundup: CBD, Love, Dolphins, and More

    Weekly Roundup: CBD, Love, Dolphins, and More0

    1. The Science Behind Falling in Love What is love? Magdalena Osial takes a dive into the cocktail of chemical reactions that happen in the brain throughout the several phases of a relationship. Usually, the attraction is associated with desire, a phenomenon intrinsically linked with the brain pathways that control “reward” behaviors. The hypothalamus produces dopamine

    READ MORE
  • Covid-19 Vaccines: A Timeline of Recent Advancements

    Covid-19 Vaccines: A Timeline of Recent Advancements0

    Images Credit: Mos.ru, CC BY 4.0, via Wikimedia Commons, Rs-nourse, CC BY-SA 4.0, via Wikimedia Commons,https://en.wikipedia.org/wiki/File:Moderna_Therapeutics_company_logo.png with UploadWizard, CC BY-SA 3.0 Press Releases: Sputnik: https://sputnikvaccine.com/newsroom/pressreleases/second-interim-analysis-of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d/ AstraZeneca: https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine FDA: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-announces-advisory-committee-meeting-discuss-covid-19-vaccine Pfizer: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine Moderna: https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy

    READ MORE
  • Weekly Roundup: Vaccines On the Way, Long-Lasting Immunity, and More

    Weekly Roundup: Vaccines On the Way, Long-Lasting Immunity, and More0

    Phase 3 is over: Pfizer’s Vaccine is 95% effective against Covid-19 On November 18, Pfizer and the German manufacturer BioNTech shared the phase 3 results from the BNT162b2 vaccine candidate. The mRNA-based COVID-19 vaccine met all the efficacy endpoints across different ages, gender, races, and ethnicities. The vaccine’s overall efficacy is 95%, and the reported side-effects

    READ MORE
  • The First Record of a SARS-CoV2 Infection Dates to One Year Ago Today

    The First Record of a SARS-CoV2 Infection Dates to One Year Ago Today0

    A 55-year-old resident of Hubei, China, may have been the first registered case of the novel coronavirus infection. The record dates to one year ago today, on the 17th of November 2019, according to Chinese official data revealed by The South China Morning Post. But the search for “patient zero” is far from over. Without

    READ MORE
  • Pfizer’s Vaccine Offers Protection against Covid19, According to Early Data

    Pfizer’s Vaccine Offers Protection against Covid19, According to Early Data0

    Pfizer’s mRNA-based vaccine candidate shows initial evidence of protection against Covid-19, the American pharmaceutical company announced today. Preliminary data from the phase 3 vaccine trials, which began on July 27, indicates the vaccine has a 90% efficacy rate in preventing Covid-19 in participants without prior evidence of Sars-Cov2 infection. The trial is taking place in

    READ MORE
  • Researchers Clone SARS-CoV2 in One Week

    Researchers Clone SARS-CoV2 in One Week0

    Cloning the novel SARS-coronavirus (SARS-CoV2) in the laboratory is now more rapid and efficient. A team of researchers from Bern, Switzerland, created a synthetic platform that produced SARS-CoV-2 copies in only one week. The results were published yesterday, as an unedited manuscript, in the scientific journal Nature. The new replication model was made using TAR

    READ MORE